Mark D. Smith - Director, Jazz Pharmaceuticals Plc
As of December 6, 2021
Mark D. Smith Net Worth
- Net worth is estimated to be at least $1.26M
- Owns at least 4,419 units of Jazz Pharmaceuticals Plc stock
- Sold an estimated value of $50.58K in the last 5 months at Jazz Pharmaceuticals Plc
Mark D. Smith Trading
- Largest sale of shares was 417 units , worth over $50.58K on December 6, 2021
- In total has made about 2 transactions over 5 months
- Usually trades in August and December, with the busiest year in 2021
Mark D. Smith
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Mark D. Smith Mailing Address
- Mailing address is C/o Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 NY
Jazz Pharmaceuticals Plc Insider Trading
- The most recent transaction was 466 units sold on May 11, 2022 by Anne O'Riordan worth over $69.41K
- In the last 15 years, insiders at Jazz Pharmaceuticals Plc sold an estimated value of $1.62B and bought an estimated value of $83.5M
- The most active traders are Bruce C Cozadd, Chairman & CEO, Michael Patrick Miller, EVP, and Patrick G Enright, Director
- Insider trading is most common in August, with the busiest year in 2014
Jazz Pharmaceuticals plc Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |